Close Menu

NEW YORK – Gestalt Diagnostics said today that it has entered two strategic collaborations for cancer pathology testing.

The firm said that it is collaborating with Westminster, Colorado-based Flagship Biosciences to develop an integrated workflow that gives pathologists access to Flagship's analysis services for digital images to support PD-L1 testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.